{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:05:19Z","timestamp":1770815119443,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.vhri.2024.101063","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T06:53:52Z","timestamp":1738392832000},"page":"101063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Utility Values of Health Status in Gastric Cancer: A Systematic Review"],"prefix":"10.1016","volume":"46","author":[{"given":"Cristian","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mat\u00edas","family":"Libuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Crispi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoldo","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Alarid-Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crist\u00f3bal","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.vhri.2024.101063_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s10120-015-0466-3","article-title":"Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?","volume":"19","author":"Fuchs","year":"2016","journal-title":"Gastric Cancer"},{"issue":"3","key":"10.1016\/j.vhri.2024.101063_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00042737-200403000-00003","article-title":"Systemic treatment of gastric cancer","volume":"16","author":"Dickson","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.vhri.2024.101063_bib5","author":"Papaioannou"},{"issue":"2","key":"10.1016\/j.vhri.2024.101063_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0266462306051051","article-title":"Use of quality-adjusted life years for the estimation of effectiveness of health care: a systematic literature review","volume":"22","author":"R\u00e4s\u00e4nen","year":"2006","journal-title":"Int J Technol Assess Heal Care"},{"issue":"2","key":"10.1016\/j.vhri.2024.101063_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1017\/S1744133109004903","article-title":"Explicit incorporation of equity considerations into economic evaluation of public health interventions","volume":"4","author":"Cookson","year":"2009","journal-title":"Heal Econ Policy Law"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S0266462300161124","article-title":"A\u00a0comparison of standard gamble, time trade-off, and adjusted time trade-off scores","volume":"16","author":"Martin","year":"2000","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vhri.2024.101063_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A\u00a0review of studies mapping (or cross walking) non preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Heal Econ"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12955-015-0344-z","article-title":"Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients","volume":"13","author":"Kiadaliri","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00005650-200001000-00013","article-title":"Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada","volume":"38","author":"Johnson","year":"2000","journal-title":"Med Care"},{"key":"10.1016\/j.vhri.2024.101063_bib12","series-title":"The EORTC QLQ-C30 Scoring Manual","year":"2001"},{"issue":"11","key":"10.1016\/j.vhri.2024.101063_bib13","first-page":"954","article-title":"Health state utility values associated with advanced gastric, oesophageal, or gastrooesophageal junction adenocarcinoma: a systematic review","volume":"18","author":"Carter","year":"2015","journal-title":"J\u00a0Med Econ"},{"issue":"3","key":"10.1016\/j.vhri.2024.101063_bib14","doi-asserted-by":"crossref","first-page":"e4705","DOI":"10.1371\/journal.pone.0004705","article-title":"Evaluaci\u00f3n de la calidad de las tecnolog\u00edas de apoyo a la decisi\u00f3n utilizando el instrumento internacional de ayuda a la decisi\u00f3n del paciente (IPDASi)","volume":"4","author":"Elwyn","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vhri.2024.101063_bib15","first-page":"109","article-title":"Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review","volume":"46","author":"Canakis","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"issue":"9","key":"10.1016\/j.vhri.2024.101063_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40273-018-0670-1","article-title":"A\u00a0practical guide to conducting a systematic review and meta-analysis of health state utility values","volume":"36","author":"Petrou","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3747\/co.22.2592","article-title":"Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer","volume":"22","author":"Lien","year":"2015","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0272989X0102100102","article-title":"A\u00a0Comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states","volume":"21","author":"Badia","year":"2001","journal-title":"Med Decis Making"},{"issue":"4","key":"10.1016\/j.vhri.2024.101063_bib19","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10120-017-0779-5","article-title":"The 8th edition of the American Joint Committee on Cancer tumor-node-metastasis staging system for gastric cancer is superior to the. 7th edition: results from a Chinese mono-institutional study of 1663 patients","volume":"21","author":"Ji","year":"2018","journal-title":"Gastric Cancer"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/0272989X10369004","article-title":"A\u00a0review and meta-analysis of utility values for lung cancer","volume":"30","author":"Sturza","year":"2010","journal-title":"Med Decis Making"},{"issue":"3","key":"10.1016\/j.vhri.2024.101063_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J\u00a0Educ Behav Stat"},{"key":"10.1016\/j.vhri.2024.101063_bib22","series-title":"Evidence Synthesis for Decision Making in Healthcare","author":"Welton","year":"2012"},{"issue":"20","key":"10.1016\/j.vhri.2024.101063_bib23","doi-asserted-by":"crossref","first-page":"10916","DOI":"10.1002\/ece3.6747","article-title":"A\u00a0contrast of meta and metafor packages for meta-analyses in R","volume":"10","author":"Christopher","year":"2020","journal-title":"Ecol Evol"},{"issue":"9","key":"10.1016\/j.vhri.2024.101063_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jval.2020.05.014","article-title":"Health state utility values in schizophrenia: a systematic review and meta-analysis","volume":"23","author":"Aceituno","year":"2020","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12874-022-01784-6","article-title":"Quality appraisal for systematic literature reviews of health state utility values: a descriptive analysis","volume":"22","author":"Muchadeyi","year":"2022","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib26","article-title":"A\u00a0systematic review and meta-analysis of prostate cancer utility values of patients and partners between 2007 and 2016","volume":"4","author":"Magnus","year":"2019","journal-title":"MDM Policy Pract"},{"key":"10.1016\/j.vhri.2024.101063_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2688","article-title":"Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis","volume":"339","author":"Arnold","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vhri.2024.101063_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/CEOR.S100448","article-title":"A\u00a0structured review of health utility measures and elicitation in advanced\/metastatic breast cancer","volume":"8","author":"Cook","year":"2016","journal-title":"Clin Outcomes Res"},{"issue":"5","key":"10.1016\/j.vhri.2024.101063_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1248\/yakushi.128.783","article-title":"Utility-based evaluation of the quality of life of Patient\u2019s with gastric cancer who receive chemotherapy\u2014comparison of patients\u2019 quality of life between oral TS-1 and conventional injectable combination therapy","volume":"128","author":"Shimizu","year":"2008","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"10.1016\/j.vhri.2024.101063_bib30","first-page":"135","article-title":"Cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: Markov decision analysis","volume":"24","author":"Wang","year":"2003","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cgh.2006.03.025","article-title":"Endoscopic screening for gastric cancer","volume":"4","author":"Dan","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.vhri.2024.101063_bib32","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3748\/wjg.14.3021","article-title":"Cost effectiveness analysis of population-based serology screening and 13C-urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model","volume":"14","author":"Xie","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vhri.2024.101063_bib33","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vhri.2024.101063_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/PPA.S151946","article-title":"Estimation of population-based utility weights for gastric cancer-related health states","volume":"12","author":"Lee","year":"2018","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"10.1016\/j.vhri.2024.101063_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15403\/jgld.2014.1121.234.hrq","article-title":"Health-related quality of life and utilities in gastric premalignant conditions and malignant lesions: a multicentre study in a high prevalence country","volume":"23","author":"Areia","year":"2014","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.vhri.2024.101063_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1477-7525-10-145","article-title":"Validation of the functional assessment of cancer therapy-gastric module for the Chinese population","volume":"10","author":"Zhou","year":"2012","journal-title":"Heal Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.vhri.2024.101063_bib37","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1524-4733.2009.00569.x","article-title":"Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments","volume":"12","author":"Kontodimopoulos","year":"2009","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.vhri.2024.101063_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11136-009-9493-z","article-title":"Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial","volume":"18","author":"Curran","year":"2009","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13283","article-title":"Health-related quality of life and health utility score of patients with gastric cancer: a multi-centre cross-sectional survey in China","volume":"29","author":"Xia","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib40","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14737167.2019.1596027","article-title":"Prognostic impact of baseline quality of life status among patients with advanced gastric cancer; results from two randomized studies","volume":"19","author":"Abdel-Rahman","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"4","key":"10.1016\/j.vhri.2024.101063_bib41","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00520-020-05729-x","article-title":"Using a Chinese time trade-off approach to explore the health utility level and quality of life of cancer patients in urban China: a multicentre cross-sectional study","volume":"29","author":"Ding","year":"2021","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.vhri.2024.101063_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s10120-021-01179-4","article-title":"QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study","volume":"24","author":"Ito","year":"2021","journal-title":"Gastric Cancer"},{"issue":"7","key":"10.1016\/j.vhri.2024.101063_bib43","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.21037\/apm-21-1599","article-title":"Evaluating health-related quality of life in gastric cancer patients in Suzhou, China","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"3","key":"10.1016\/j.vhri.2024.101063_bib44","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ejso.2021.08.031","article-title":"Health related quality of life following open versus minimally invasive total gastrectomy for cancer: results from a randomized clinical trial","volume":"48","author":"van der Wielen","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.vhri.2024.101063_bib45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2147\/PPA.S138028","article-title":"Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China","volume":"11","author":"Liu","year":"2017","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"10.1016\/j.vhri.2024.101063_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10198-022-01465-7","article-title":"Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China","volume":"24","author":"Weng","year":"2023","journal-title":"Eur J Heal Econ"},{"issue":"6","key":"10.1016\/j.vhri.2024.101063_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/0272989X14536779","article-title":"A\u00a0review and meta-analysis of colorectal cancer utilities","volume":"34","author":"Djalalov","year":"2014","journal-title":"Med Decis Making"},{"issue":"8","key":"10.1016\/j.vhri.2024.101063_bib48","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10198-021-01335-8","article-title":"Health state utility values by cancer stage: a systematic literature review","volume":"22","author":"Pourrahmat","year":"2021","journal-title":"Eur J Heal Econ"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12955-017-0748-z","article-title":"A\u00a0systematic literature review of health state utility values in head and neck cancer","volume":"15","author":"Meregaglia","year":"2017","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.vhri.2024.101063_bib50","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jval.2020.04.1825","article-title":"EQ-5D\u2013derived health state utility values in hematologic malignancies: a catalog of 796 utilities based on a systematic review","volume":"23","author":"Golicki","year":"2020","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.vhri.2024.101063_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"Br Med Bull"},{"issue":"5","key":"10.1016\/j.vhri.2024.101063_bib52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hec.3871","article-title":"Frequentist and Bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data","volume":"28","author":"Hatswell","year":"2019","journal-title":"Health Econ"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T03:05:03Z","timestamp":1742439903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109924000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"alternative-id":["S2212109924000967"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101063","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility Values of Health Status in Gastric Cancer: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101063"}}